Moreover, treatment with an anti-S100A8 antibody induced a similar impact on AML cell differentiation as observed with treatment with recombinant S100A9 protein that both prolonged survival in the same mouse model of AML [32]. Here, S100A8 is linked to acute myeloid leukemia.